BRPI0513741A - processo de melhoria da imunogeneicidade de um imunogene, antìgeno ou hapteno, complexo imunogênico, ácido nucleico e utilização de um complexo imunogênico - Google Patents

processo de melhoria da imunogeneicidade de um imunogene, antìgeno ou hapteno, complexo imunogênico, ácido nucleico e utilização de um complexo imunogênico

Info

Publication number
BRPI0513741A
BRPI0513741A BRPI0513741-1A BRPI0513741A BRPI0513741A BR PI0513741 A BRPI0513741 A BR PI0513741A BR PI0513741 A BRPI0513741 A BR PI0513741A BR PI0513741 A BRPI0513741 A BR PI0513741A
Authority
BR
Brazil
Prior art keywords
immunogenic complex
immunogenicity
antigen
peptide
immunogen
Prior art date
Application number
BRPI0513741-1A
Other languages
English (en)
Inventor
Christine Libon
Thien Nguyen
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of BRPI0513741A publication Critical patent/BRPI0513741A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18511Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PROCESSO DE MELHORIA DA IMUNOGENEICIDADE DE UM IMUNOGENE, ANTìGENO OU HAPTENO, COMPLEXO IMUNOGêNICO, áCIDO NUCLEICO E UTILIZAçãO DE UM COMPLEXO IMUNOGêNICO A presente invenção refere-se a um processo permitindo melhorar a imunogenicidade de um imunogene, antígeno ou hapteno, por copulação com um peptídeo suporte de tamanho pequeno. Mais particularmente, a presente invenção refere-se a um processo de preparação de um complexo imunogênico assim com os complexos susceptíveis de serem obtidos por um tal processo, e a utilização de tais complexos a título de medicamento para aumentar a imunogenicidade de um imunogene. A invenção compreende notadamente um peptídeo suporte copulado com um peptídeo proveniente da proteína G do vírus respiratório sincicial (VRS) e sua utilização a título vacinal para o tratamento de infecções respiratórias ligadas ao VRS.
BRPI0513741-1A 2004-07-23 2005-07-25 processo de melhoria da imunogeneicidade de um imunogene, antìgeno ou hapteno, complexo imunogênico, ácido nucleico e utilização de um complexo imunogênico BRPI0513741A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0408175A FR2873378A1 (fr) 2004-07-23 2004-07-23 Complexes immunogenes, leur procede de preparation et leur utilisation dans des compositions pharmaceutiques
PCT/FR2005/001913 WO2006018527A1 (fr) 2004-07-23 2005-07-25 Complexes immunogenes, leur procede de preparation et leur utilisation dans des compositions pharmaceutiques

Publications (1)

Publication Number Publication Date
BRPI0513741A true BRPI0513741A (pt) 2008-05-13

Family

ID=34947471

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0513741-1A BRPI0513741A (pt) 2004-07-23 2005-07-25 processo de melhoria da imunogeneicidade de um imunogene, antìgeno ou hapteno, complexo imunogênico, ácido nucleico e utilização de um complexo imunogênico

Country Status (14)

Country Link
US (1) US20080300382A1 (pt)
EP (1) EP1776379A1 (pt)
JP (1) JP2008512986A (pt)
KR (1) KR20070058457A (pt)
CN (1) CN1989150A (pt)
AU (1) AU2005273779A1 (pt)
BR (1) BRPI0513741A (pt)
CA (1) CA2574340A1 (pt)
FR (1) FR2873378A1 (pt)
IL (1) IL180900A0 (pt)
MX (1) MX2007000887A (pt)
NO (1) NO20071030L (pt)
RU (1) RU2007106900A (pt)
WO (1) WO2006018527A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA021393B1 (ru) 2007-12-24 2015-06-30 Глаксосмитклайн Байолоджикалс С.А. Рекомбинантные антигены rsv
BRPI0915960A2 (pt) * 2008-07-18 2019-09-24 Id Biomedical Corp antígenos de polipeptídeos do vírus sincicial respiratório qimérico
JP5796011B2 (ja) 2009-06-24 2015-10-21 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
SI2445526T1 (sl) 2009-06-24 2016-08-31 Glaxosmithkline Biologicals S.A. Rekombinantni RSV antigeni
ES2918381T3 (es) 2009-07-15 2022-07-15 Glaxosmithkline Biologicals Sa Composiciones de proteína F de VRS y métodos para producir las mismas
KR20120081587A (ko) 2009-09-10 2012-07-19 노파르티스 아게 기도 질병에 대한 조합 백신

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726471B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Procede pour ameliorer l'immunogenicite d'un compose immunogene ou d'un haptene et application a la preparation de vaccins
FR2798292A1 (fr) * 1999-09-09 2001-03-16 Pf Medicament Utilisation d'ammoniums quaternaires aliphatiques pour induire une reponse mixte th1/th2
FR2827606A1 (fr) * 2001-07-20 2003-01-24 Pf Medicament Nouveaux derives d'anatoxines diphteriques et leur utilisation comme porteur

Also Published As

Publication number Publication date
IL180900A0 (en) 2007-07-04
US20080300382A1 (en) 2008-12-04
RU2007106900A (ru) 2008-09-10
NO20071030L (no) 2007-04-23
MX2007000887A (es) 2007-03-12
JP2008512986A (ja) 2008-05-01
WO2006018527A1 (fr) 2006-02-23
CA2574340A1 (fr) 2006-02-23
KR20070058457A (ko) 2007-06-08
AU2005273779A1 (en) 2006-02-23
CN1989150A (zh) 2007-06-27
EP1776379A1 (fr) 2007-04-25
FR2873378A1 (fr) 2006-01-27

Similar Documents

Publication Publication Date Title
CL2008002559A1 (es) Construccion que comprende un vector de fluorocarbono y un antigeno del virus de la influenza; composicion farmaceutica que lo comprende; y su uso para aumentar la respuesta inmunologica
JP2008508859A5 (pt)
WO2004092360A3 (en) The severe acute respiratory syndrome coronavirus
BRPI0513741A (pt) processo de melhoria da imunogeneicidade de um imunogene, antìgeno ou hapteno, complexo imunogênico, ácido nucleico e utilização de um complexo imunogênico
DK1618889T3 (da) Influenzavaccine
JP2014534202A5 (pt)
WO2009095226A3 (en) NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS
WO2002056905A3 (en) Molecular antigen array
JP2011504486A5 (pt)
DE602006019629D1 (de) Von zellen stammende virale impfstoffe mit geringen mengen an rest-zell-dna
BRPI0513819A (pt) inibidores de hsp90
JP2009539965A5 (pt)
WO2009060281A3 (en) Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
FR2827605B1 (fr) Nouveaux peptides derives de la proteine g du vrs et leur utilisation dans un vaccin
NO20090178L (no) Vaksiner for malaria
WO2009009759A3 (en) Yersinia pestis antigens, vaccine compositions, and related methods
WO2006027300A3 (en) Carrier conjugates of gnrh-peptides
WO2009080715A3 (en) Vaccines for malaria
DK1441764T3 (da) Antigen-Arrays der omfatter RANKL til behandling af knoglesygdom
Kozak et al. The integrated consideration of vaccine platforms, adjuvants, and delivery routes for successful vaccine development
WO2009074861A3 (en) Improved vaccine
NO20075194L (no) vaksine
WO2006024240A3 (es) Composición vacunal contra el virus de la hepatitis c.
HUP0400840A2 (hu) Kis molekulatömegű hialuronsav immunogén készítményei, és eljárások A. csoportbeli és C. csoportbeli Streptococcusok által okozott fertőzések és betegségek megelőzéséhez, kezeléséhez és diagnózisához
SE9903534D0 (sv) Vaccin

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.